Mijia Wu serves as Executive at NovaBay Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Mijia Wu has executed 7 insider transactions totaling $187.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on May 11, 2023 involved exercising options for 858 shares valued at $0.
Mijia Wu currently holds 1,716 shares of NovaBay Pharmaceuticals, Inc. (NBY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mijia Wu has been a net seller of NBY stock. They have purchased $0 and sold $187.8K worth of shares.
Mijia Wu's most recent insider trade was on May 11, 2023, when they sold 858 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 17, 2020 | NBY | $6.0K | Award | 20,000 | $0.30 | Discretionary |
| Aug 17, 2020 | NBY | $27.0K | Sale | 20,000 | $1.35 | Discretionary |
| Jun 11, 2019 | NBY | $64.1K | Sale | 15,873 | $4.04 | Discretionary |
| Jun 10, 2019 | NBY | $96.7K | Sale | 47,619 | $2.03 | Discretionary |
| Sep 30, 2016 | NBY | $50.0K | Exercise | 15,873 | $3.15 | Discretionary |